OQROGet OQRO Pro
Politician trade (House)

Bio-Techne (TECH)Rep. April McClain Delaney (MD06) disclosed a purchase $1K–$15K

Rep. April McClain Delaney (MD06) disclosed a purchase of Bio-Techne in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
13 days
Disclosure lag
Traded
Oct 22, 2025
Disclosed
Nov 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 1, 2025CongressDisclosed partial sale of TECH — reported range $1,001 - $15,000
  2. Aug 25, 2025Insider · 2 peopleInsiders: 2 sales (~$1.9M)
  3. Oct 22, 2025 · this disclosureCongressDisclosed purchase of TECH — reported range $1,001 - $15,000

What came next

  1. Oct 30, 2025Company filing · Form 8-K · Results, Shareholder voteReported its results, and held a shareholder vote (and 1 more item)
  2. Nov 14, 20255% stakeT. Rowe Price Associates, Inc. reported a passive stake (13G) of 2.2%
  3. Dec 2, 2025CongressDisclosed purchase of TECH — reported range $1,001 - $15,000
  4. Dec 5, 2025CongressDisclosed purchase of TECH — reported range $1,001 - $15,000
  5. Jan 28, 2026CongressDisclosed partial sale of TECH — reported range $1,001 - $15,000
  6. Feb 4, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  7. Feb 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On February 11, 2026, Bio-Techne Corporation (the “Company”) announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026, and will remain with Bio-Techne for a period of time to support a smooth transition.”
  8. Feb 17, 2026InsiderDirector sold ~$117K of TECH shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Bio-Techne

For Bio-Techne, OQRO holds 18 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TECH page.

Other recent filings by Rep. April McClain Delaney (MD06)

The full history of Rep. April McClain Delaney (MD06) is on the profile page.

How this filing works

Other disclosures at Bio-Techne

Everything OQRO holds on this company is on its TECH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data